Does Blue Cross Blue Shield of Minnesota Cover Metformin?

How BCBS MN Classifies Metformin on Its Formulary

Blue Cross Blue Shield of Minnesota uses a multi-tier formulary system to organize covered medications by cost. Generic metformin hydrochloride, the most widely prescribed oral diabetes drug in the United States, lands on Tier 1 across the majority of BCBS MN plan designs. This placement reflects its status as a first-line therapy for type 2 diabetes per the American Diabetes Association (ADA) Standards of Care.

Tier 1 vs. Tier 2 Placement

Tier 1 drugs carry the lowest out-of-pocket cost. Metformin immediate-release (IR) tablets in 500 mg, 850 mg, and 1,000 mg strengths consistently appear at this level. Metformin extended-release (ER) tablets sometimes sit on Tier 2 depending on the specific plan year and benefit design, which can increase the copay by $5 to $20 per fill.

Brand-Name Formulations

Glucophage (brand IR) and Glucophage XR (brand ER) are placed on Tier 3 or the non-preferred brand tier when they appear on the formulary at all. Some BCBS MN plans exclude brand metformin entirely when a therapeutically equivalent generic is available. Riomet, the liquid metformin formulation, may require prior authorization and occupies a specialty or non-preferred tier on most plans.

Why Tier Placement Matters for Your Wallet

The difference between Tier 1 and Tier 3 can mean paying $5 versus $50 or more for the same active ingredient. A 2023 analysis published in JAMA Internal Medicine found that formulary tier placement was the single largest predictor of out-of-pocket diabetes medication costs for commercially insured patients, outweighing even deductible size [1]. For metformin specifically, sticking with the generic IR formulation almost always produces the lowest cost.

Copay Ranges and Out-of-Pocket Costs

The actual dollar amount you pay depends on your plan type, pharmacy network status, and whether you have met your deductible. BCBS MN offers several product lines with different cost-sharing structures.

Individual and Family Plans (ACA Marketplace)

On BCBS MN's ACA-compliant individual and family plans, generic metformin IR copays typically range from $0 to $10 after any applicable deductible. Some Silver and Gold tier marketplace plans waive the deductible for Tier 1 generics entirely, meaning you pay the flat copay from your first fill.

An important wrinkle: the U.S. Preventive Services Task Force (USPSTF) issued a grade B recommendation for metformin use in adults with prediabetes who are at high risk for type 2 diabetes progression [2]. Under ACA rules, services and medications tied to grade A or B USPSTF recommendations must be covered with no cost-sharing. If your provider prescribes metformin specifically for prediabetes prevention, your BCBS MN marketplace plan may be required to cover it at $0.

Employer-Sponsored Group Plans

Group plan copays for generic metformin range from $5 to $15 for a 30-day supply at an in-network retail pharmacy. Large employer groups that self-fund through BCBS MN's administrative services often negotiate even lower generic copays. Some fully insured small-group plans apply a flat $10 copay to all Tier 1 drugs.

Medicare Advantage Plans

BCBS MN's Medicare Advantage (Part C + Part D) plans cover metformin under the Part D prescription drug benefit. In 2026, most BCBS MN Medicare Advantage plans list generic metformin at $0 to $5 copay during the initial coverage phase. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D spending, fully in effect since 2025, means metformin costs count toward a hard ceiling that protects high-utilization beneficiaries [3].

Mail-Order Savings

BCBS MN partners with mail-order pharmacy services, including Prime Therapeutics, for 90-day fills. A 90-day mail-order supply of generic metformin often costs the equivalent of two retail copays rather than three, saving roughly 33% per tablet over the course of a year.

Prior Authorization and Step Therapy Requirements

Generic metformin IR does not require prior authorization on any current BCBS MN formulary. This is consistent with national trends: a 2022 survey by the American Medical Association found that 91% of physicians reported prior authorization delays for at least some medications, but first-line generics like metformin were almost universally exempt.

When Prior Authorization May Apply

Prior authorization or step therapy can apply in specific situations:

• Brand-name requests. If a prescriber writes for Glucophage or Glucophage XR instead of the generic, BCBS MN may require documentation of generic intolerance or treatment failure before covering the brand.
• High-dose regimens. Prescriptions exceeding the standard quantity limit (typically 120 tablets of 500 mg or 60 tablets of 1,000 mg per 30 days) may trigger a quantity limit exception review.
• Riomet liquid formulation. Because an oral tablet alternative exists, the liquid form almost always requires clinical justification.

How to Handle a Denial

If BCBS MN denies coverage for a specific metformin formulation, you or your prescriber can file a formulary exception request. The process involves submitting clinical documentation showing why the standard alternative is inappropriate. BCBS MN must respond within 72 hours for standard requests or 24 hours for expedited (urgent) reviews, per Minnesota Department of Commerce regulations.

Metformin for Off-Label and Preventive Uses

Metformin's evidence base extends well beyond type 2 diabetes management. Prescribers increasingly write metformin for off-label indications, and BCBS MN's coverage response varies by use case.

Prediabetes Prevention

The Diabetes Prevention Program (DPP) trial demonstrated that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% over 2.8 years in high-risk adults, compared to placebo [4]. The 15-year follow-up of the DPP Outcomes Study showed persistent risk reduction of 18% in the metformin group [5]. As noted above, ACA-compliant BCBS MN plans should cover metformin at $0 cost-sharing when prescribed for prediabetes prevention under the USPSTF recommendation.

Polycystic Ovary Syndrome (PCOS)

Metformin is commonly prescribed off-label for PCOS, particularly for menstrual irregularity and insulin resistance. The Endocrine Society's 2023 clinical practice guideline recommends metformin as a second-line agent for menstrual irregularity in PCOS when hormonal contraceptives are contraindicated. BCBS MN generally covers metformin for PCOS without additional prior authorization because the drug itself remains on formulary regardless of diagnosis code.

Longevity and Anti-Aging Research

The Targeting Aging with Metformin (TAME) trial, a planned six-year study across 14 centers, aims to determine whether metformin can delay age-related diseases in non-diabetic older adults [6]. While TAME has not yet produced primary results, observational data from the UK Clinical Practice Research Datalink found that type 2 diabetes patients on metformin monotherapy had a 15% lower all-cause mortality rate than matched non-diabetic controls [7]. BCBS MN does not specifically cover metformin for "anti-aging" purposes, but because generic metformin copays are so low, the practical cost barrier is minimal if a prescriber writes the prescription.

How to Verify Your Specific BCBS MN Metformin Coverage

Plan documents vary. The formulary that applied to your coworker's BCBS MN plan may differ from yours, even within the same employer group. Here is a step-by-step process to confirm your coverage.

Step 1: Check the Online Formulary

Log into your member account at bluecrossmn.com. Manage to "Find a Drug" or "Formulary Search" and type "metformin." The tool will show the tier, any quantity limits, and whether prior authorization is required for your specific plan.

Step 2: Call Member Services

The phone number on the back of your BCBS MN ID card connects you to a benefits specialist who can confirm copay amounts, deductible application, and preferred pharmacy network status. Ask specifically: "Is metformin HCl [your dose] on Tier 1 for my plan, and does my deductible apply before the copay kicks in?"

Step 3: Ask Your Pharmacist for a Test Claim

Any in-network pharmacy can run a test adjudication claim through BCBS MN's system without actually dispensing the medication. This gives you the exact copay amount in real time. It takes about two minutes.

Step 4: Request a Formulary Exception if Needed

If your plan covers metformin ER at a higher tier and your prescriber believes the ER formulation is medically necessary (for example, due to GI side effects with IR), ask the prescriber to submit a formulary exception. Approval rates for metformin tier exceptions are high because the cost difference to the plan is small.

Metformin Side Effects and Monitoring Considerations

Coverage is only useful if the drug is tolerable. Metformin's most common side effects are gastrointestinal: nausea, diarrhea, abdominal discomfort, and metallic taste. These affect roughly 25% to 30% of patients in the first weeks of treatment and typically resolve with dose titration.

GI Tolerability Strategies

Starting at 500 mg once daily with food and increasing by 500 mg every one to two weeks reduces GI side effect rates substantially. The extended-release formulation produces fewer GI symptoms than immediate-release in head-to-head comparisons; a randomized crossover trial showed a 50% reduction in GI adverse events with ER versus IR metformin at equivalent doses [8].

Vitamin B12 Monitoring

Long-term metformin use (more than four years) is associated with vitamin B12 deficiency in approximately 5% to 10% of patients. The ADA recommends periodic B12 level checks in patients on chronic metformin therapy, particularly those with peripheral neuropathy symptoms. BCBS MN covers serum B12 testing as a standard laboratory benefit.

Lactic Acidosis Risk

Metformin-associated lactic acidosis is rare, occurring at an estimated rate of 4.3 cases per 100,000 patient-years. The risk increases meaningfully only in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²). Current FDA labeling permits metformin use down to an eGFR of 30, with dose reduction recommended between 30 and 45.

Renal Function Monitoring

BCBS MN covers the basic metabolic panel and eGFR calculation that prescribers use to monitor renal function before and during metformin therapy. The ADA recommends checking renal function at least annually, and every three to six months in patients with eGFR between 30 and 60 [9].

How BCBS MN Metformin Coverage Compares to Other Minnesota Insurers

BCBS MN is not the only insurer operating in Minnesota, and metformin coverage is broadly similar across carriers because the drug is inexpensive and universally guideline-recommended.

HealthPartners

HealthPartners places generic metformin on Tier 1 with $0 to $10 copays, nearly identical to BCBS MN. Mail-order 90-day fills are available through HealthPartners Mail Order Pharmacy.

Medica

Medica's 2026 formularies list generic metformin at Tier 1. Copays range from $0 to $12 depending on the plan. Medica also waives cost-sharing for metformin prescribed for prediabetes prevention on ACA plans.

UCare

UCare, which serves Minnesota's Medicaid (Medical Assistance) and Medicare populations, covers metformin with $0 to $3 copays on most plans. Medicaid recipients pay $0 or $1 for generic metformin.

The Bottom Line on Carrier Comparison

Generic metformin is one of the least expensive prescription drugs on the market. The average wholesale acquisition cost is approximately $0.03 per 500 mg tablet. Because the drug costs insurers almost nothing to cover, tier placement and copay structures are favorable across all major Minnesota carriers. The choice between BCBS MN and competitors should rarely hinge on metformin coverage alone.

Metformin Prescribing Trends in Minnesota

Minnesota has a lower age-adjusted diabetes prevalence (7.4%) than the national average (11.6%), according to CDC data from 2023. Despite this, metformin prescribing volumes in the state have grown steadily, driven partly by increased prediabetes screening and off-label use.

The Minnesota Department of Health reported that prediabetes affects an estimated 1.5 million Minnesota adults. With the USPSTF recommendation and ACA cost-sharing protections in place, BCBS MN members with prediabetes have a clear coverage pathway for metformin at no out-of-pocket cost.